AllianceBernstein’s BioNTech BNTX Stock Holding History

AllianceBernstein’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-45,005	Closed	-$5.61M	–	3177
2023 Q1	$5.61M	Buy	+45,005	New	+$6.18M	﹤0.01%	1354
2022 Q2	–	Sell	-10,000	Closed	-$1.71M	–	3275
2022 Q1	$1.71M	Sell	10,000 -5,000	-33%	-$840K	﹤0.01%	2182
2021 Q4	$3.87M	Buy	+15,000	New	+$4.11M	﹤0.01%	1759

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AllianceBernstein's BNTX Position: Q2 2023 in Review

AllianceBernstein sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 45,005 shares — an estimated $5.61M sold.

AllianceBernstein first reported a position in BNTX in Q4 2021 and held it in 3 quarters. The position peaked at $5.61M in Q1 2023. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

AllianceBernstein reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
AllianceBernstein sold 45,005 BioNTech shares in Q2 2023, an estimated $5.61M.
AllianceBernstein first reported a position in BioNTech in Q4 2021 and held it in 3 quarters.
AllianceBernstein's BioNTech position peaked at $5.61M in Q1 2023.
253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on AllianceBernstein's 13F filing for Q2 2023, filed 15 Aug 2023.